Considering that the mechanism by which coactivator p300 promotes gene transcription may vary among gene targets, it is not very difficult for us to understand that the function of p300 and its underling mechanism(s) to impact cancer progression may lead to this discrepancy. This evidence concerns the gene EP300 and cancer.